Aveanna Healthcare Holdings PE Ratio 2020-2023 | AVAH
Current and historical p/e ratio for Aveanna Healthcare Holdings (AVAH) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aveanna Healthcare Holdings PE ratio as of April 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Aveanna Healthcare Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-26 | 2.20 | 0.00 | |
2023-12-31 | 2.68 | $-0.71 | 0.00 |
2023-09-30 | 1.19 | $-1.86 | 0.00 |
2023-06-30 | 1.69 | $-1.19 | 0.00 |
2023-03-31 | 1.04 | $-3.88 | 0.00 |
2022-12-31 | 0.78 | $-3.57 | 0.00 |
2022-09-30 | 1.50 | $-2.97 | 0.00 |
2022-06-30 | 2.26 | $-3.09 | 0.00 |
2022-03-31 | 3.41 | $-0.52 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.423B | $1.895B |
Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
DaVita (DVA) | United States | $11.709B | 15.93 |
Chemed (CHE) | United States | $8.472B | 26.30 |
Encompass Health (EHC) | United States | $8.259B | 21.25 |
Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
Option Care Health (OPCH) | United States | $5.147B | 19.48 |
RadNet (RDNT) | United States | $3.314B | 96.80 |
Amedisys (AMED) | United States | $2.999B | 21.25 |
LifeStance Health (LFST) | United States | $2.370B | 0.00 |
Astrana Health (ASTH) | United States | $2.057B | 25.68 |
Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
Pennant (PNTG) | United States | $0.624B | 36.46 |
Atai Life Sciences (ATAI) | Germany | $0.323B | 0.00 |
Daxor (DXR) | United States | $0.046B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
Psychemedics (PMD) | United States | $0.015B | 0.00 |
Ontrak (OTRK) | United States | $0.014B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
IMAC Holdings (BACK) | United States | $0.005B | 0.00 |